Cerebrolysin
What is it?
A brain-derived peptide preparation containing a mixture of small peptides and amino acids. The neuropeptide literature discusses it separately from Cortexin and defined short peptides.
Identity / background source ↗
Research context
Included in the 2013 neuropeptide comparison. A distinct preparation and developmental lineage; findings for Cortexin or short peptides cannot be transferred to it.
- Working classification
- Polypeptide preparation
- Research collection
- Neuropeptide research · editorial grouping
- Institutional provenance
- Not established for this compound record
- Last evidence review
- Full evidence review pending; source-check scope appears with each publication below.
What do we know?
- Human research
- —Not assessed
- Study methods
- —Not assessed
- Independent replication
- —Not assessed
- Source access
- —See linked publication and review scope
- Safety evidence
- —Not assessed
These are independent review fields, not a rating. Missing evidence in this starter does not mean no research exists.
Linked sources
Explore the research map and unresolved leads ↗
Neuroprotective effects of peptides bioregulators in people of various age
R. S. Umnov, N. S. Linkova, V. Kh. Khavinson · Adv Gerontol. 26(4):671–678. PMID 24738258
A gateway review comparing polypeptide complexes (Cortexin and Cerebrolysin) with short peptides (Semax, Cortagen and Pinealon). It discusses older populations and cellular mechanisms; the abstract supplies no trial-quality assessment.
- Population / setting
- Review of earlier research
- What was checked
- Indexed English abstract checked; Russian full text not retrieved.
Limitations & review scope
- Source-linked does not mean a completed risk-of-bias review.
- A review is not an independent clinical replication; proposed mechanisms do not establish efficacy or safety.
Source checked 2026-09-27. This is a source-linked record, not a completed evidence review.